What is it about?
Using a very simple microfluidic reactor we were able to prepare Zr-89 labeled Herceptin much faster than conventional methods while meeting all quality control tests required for clinical use.
Featured Image
Read the Original
This page is a summary of: Microfluidic Preparation of a 89Zr-Labeled Trastuzumab Single-Patient Dose, Journal of Nuclear Medicine, January 2016, Society of Nuclear Medicine,
DOI: 10.2967/jnumed.115.166140.
You can read the full text:
Contributors
The following have contributed to this page
